Judicious application of invasive and noninvasive testing, particularly for assessing left ventricular systolic function, is essential after myocardial infarction.
Answers are grounded in this paper and cite their sources.
Supports selective post-MI testing for LV function; leaves open optimal protocols in contemporary cohorts.
Both physicians and patients should be encouraged by the tremendous progress made in the clinical care of patients with heart disease during the last 20 years. However, the number of invasive and noninvasive tests is vast, so they need to be applied judiciously, using a reasonable set of clinical principles to recognize the needs of the individual patient. In the case of myocardial infarction, one of the most important prognostic factors is left ventricular systolic function, which is commonly measured by the ejection fraction. This measurement can be made with a left ventriculogram, radionuclide ventriculogram, or two-dimensional echocardiogram, the choice depending on individual circumstances.
No takes yet. Share an insight, caveat, or question.
Robert E. Safford (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: